Related Experiment Video
Updated: Aug 30, 2025

04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
892
Cervical Lymph Node Metastasis Differences in Patients with Unilateral or Bilateral Papillary Thyroid Microcarcinoma:
Zheyu Yang1, Yu Heng2, Weihua Qiu1,3
1Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Journal of Clinical Medicine
|August 26, 2022
Summary
Bilateral papillary thyroid microcarcinomas (PTMC) show higher lymph node metastasis risk than unilateral PTMC. A new evaluation system quantifies metastasis risk for tailored neck treatment strategies.
Area of Science:
- Endocrinology
- Oncology
- Surgical Pathology
Background:
- Papillary thyroid microcarcinoma (PTMC) poses a risk of lymph node metastasis.
- Accurate risk stratification is crucial for guiding neck treatment strategies.
Purpose of the Study:
- To develop quantitative models for predicting central (CLNM) and lateral lymph node metastasis (LLNM) in unilateral and bilateral PTMC.
- To guide individualized surgical and adjuvant treatment strategies for PTMC patients.
Main Methods:
- Analysis of 717 PTMC patients from three medical centers.
- Identification of independent risk factors for CLNM and LLNM in unilateral and bilateral PTMC.
- Development of predictive models for lymph node metastasis risk.
Main Results:
- Bilateral PTMCs exhibit a significantly higher CLNM and LLNM rate compared to unilateral PTMCs.
- Identified independent risk factors for CLNM/LLNM in unilateral PTMC include age, sex, tumor diameter, capsular invasion, multifocality, and nodular goiter.
- Identified independent risk factors for CLNM/LLNM in bilateral PTMC include age, capsular invasion, multifocality, positive lymph node size, and nodular goiter.
Conclusions:
- An evaluation system based on identified risk factors for CLNM and LLNM in PTMC has been established.
- This system effectively quantifies metastasis risk, aiding in personalized treatment decisions for unilateral and bilateral PTMC.
- The evaluation system supports optimized surgical and postoperative adjuvant treatments for the neck region.

